Global /India /Healthcare /Drug Manufacturers - General /DCAL

Dishman Carbogen Amcis Ltd.

DCAL

• NSE: DCAL • Delayed

183.18INR 1%

1.94 USD

As of 20 June 2026, Dishman Carbogen Amcis Ltd. has a market cap of $301.16M USD, ranking #18573 globally and #1028 in India. It ranks #1679 in the Healthcare sector, and #610 in the Drug Manufacturers - General industry.

Global Rank

18573

Country Rank

1028

Sector Rank

1679

Industry Rank

610

Key Stats

Market Cap

$301.16MUSD

28.42B INR

Enterprise Value

$505.18MUSD

47.7B INR

Revenue (TTM)

$296.32MUSD

27.97B INR

EBITDA (TTM)

$51.25MUSD

4.84B INR

Net Income (TTM)

$12.59MUSD

1.19B INR

EBITDA Margin

17%

Profit Margin

4.2%

PE Ratio

23.9

PS Ratio

1.0

PB Ratio

0.4

EV/EBITDA

8.9

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Arpit Vyas open_in_new

Employees

1,106

Founded

1983

Website

imdcal.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1%	6.9%	27%	-12%	-39%	-27%	-11%	31%	12%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	DCAL Dishman Carbogen Amics Ltd ISIN: INE385W01011 Shares Out.: Shares Outstanding: 156.783M¹ Shares Float: 51.589M² TV: TradingView: NSE: DCAL SA: Stock Analysis: NSE: DCAL YF: Yahoo Finance: DCAL.NS GF: Google Finance: NSE: DCAL BA: Barron's: DCAL MS: Morningstar: XNSE: DCAL	183.18 INR	TV: TradingView: NSE: DCAL SA: Stock Analysis: NSE: DCAL YF: Yahoo Finance: DCAL.NS GF: Google Finance: NSE: DCAL BA: Barron's: DCAL MS: Morningstar: XNSE: DCAL
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	540701 (DCAL) Dishman Carbogen Amics Ltd ISIN: INE385W01011 TV: TradingView: BSE: DCAL SA: Stock Analysis: BOM: 540701 YF: Yahoo Finance: 540701.BO GF: Google Finance: BOM: 540701 BA: Barron's: 540701 MS: Morningstar: XBOM: 540701	181.30 INR	TV: TradingView: BSE: DCAL SA: Stock Analysis: BOM: 540701 YF: Yahoo Finance: 540701.BO GF: Google Finance: BOM: 540701 BA: Barron's: 540701 MS: Morningstar: XBOM: 540701

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Dishman Carbogen Amcis Ltd.

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 15K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 6K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 5K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 4K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 3K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 3K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 253K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 182K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 120K%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 106K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 94K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 91K%	15.1	United States

chevron_leftBack